HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity.

AuthorsDiana Hernández-Flórez, Lara Valor
JournalReumatologia clinica (Reumatol Clin) 2016 Nov - Dec Vol. 12 Issue 6 Pg. 303-306 ISSN: 1885-1398 [Electronic] Spain
Vernacular TitleInhibidores selectivos de fosfodiesterasas, una nueva opción terapéutica en inflamación y autoinmunidad.
PMID27567299 (Publication Type: Editorial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Phosphodiesterase 4 Inhibitors
  • Thalidomide
  • apremilast
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Autoimmune Diseases (drug therapy)
  • Humans
  • Inflammation (drug therapy)
  • Phosphodiesterase 4 Inhibitors (therapeutic use)
  • Thalidomide (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: